Ukuthuthukiswa komgomo we-Herpes: Okuphambili kanye nenqubekela phambili

Ukufuna umgomo wokuvikela emilonyeni ye-herpes yomlomo kanye ne- herpes yesisu sekuyisikhathi eside. Abacwaningi bebelokhu bezama imithi yokugoma kusukela okungenani ekuqaleni kwawo-1930. Ngeshwa, kube khona impumelelo encane. Nakuba imishanguzo ye-herpes iye yasungulwa ngamagundane, izilingo zabantu azizange ziphumelele. Nakuba ezinye izitofu ze-herpes zivele zinezithembiso, ukuhlolwa okunamandla kubonise ukuthi akuzona kangcono kune-placebo.

Imishanguzo ye-Herpes Virus ekhona

Ukukhuluma ngokweqile, sekukhona imithi eminingi ye-herpes emakethe. Kodwa-ke, nakuba lezi mishanguzo zivikela ama-viruses emndenini we-herpes, azivikeleli ngokumelene nama-herpes omzimba noma omlomo.

Umuthi wokugoma we-shingles nomgomo wokukhukhuka ubheke izindlela ezimbili umuthi wokugoma we-herpes simplex ongasebenza. Umuthi wokugoma we- chickenpox , noma i-varicella zoster virus (VZV), unikezwa ukuvikela abantu abaye bahlaselwa yi-VZV. Ngokuphambene nalokho, umgomo we-shingles unikezwa ukunciphisa amathuba okuthi igciwane elikhona lizophinde livuselele, kubangele ukukhwabanisa kwesifo.

Lezi zifana nezinhlobo ezimbili zemishanguzo ehlongozwayo ukuvikela emilonyeni yomlomo ne-herpes. Uhlobo olulodwa lokugoma luyoba ngabantu abangakaze batheleleke, ukuvikela igciwane. Olunye uhlobo lomuthi wokugoma luyoba ngabantu abanesifo se-herpes , ukuvikela ukuqhuma.

I-Herpes Vaccine Priorities From World Health Organization

Ngokwemvelo, kunengqondo ukuthi umuthi wokugoma ungasebenza ukuvimbela ukuqubuka kwe-herpes. Phela, kubantu abaningi, amasosha omzimba alawula izifo ze-herpes ukuze zingenayo izimpawu . Lokhu kwenza igciwane libe yinto enhle yokuthola umuthi wokugoma, nakuba kungenalo i-target ye-HPV .

Ngeshwa, amagciwane e-herpes simplex abangela i-herpes yesisu nangokwemlomo aqinisekisile ukuthi kunzima ukulawula ngemigomo.

Ngo-2017, i-World Health Organization (WHO) ichaza uchungechunge lwezinto ezibalulekile ekuthuthukiseni umgomo wokugoma i-herpes. Lokhu okubalulekile kwakuwumphumela wenkomfa yabathintekayo abavela emhlabeni jikelele ukuthola ukuthi iziphi izifo zomuthi wokugoma we-herpes zizobaluleka kakhulu. Iqembu lezinto eziza kuqala kulokhu bekuyi:

U-WHO uphakamise ukuthi izinhlobo ezimbili zemigomo zingase zisebenzise ukutheleleka kwe-herpes simplex. Imishanguzo ye-prophylactic, njengegciwane lesikhumba, lingasiza ekuvimbeleni abantu ukuba bangalokothi bathole i-herpes. Imishanguzo yokwelapha, njengegciwane lesigciwane, inganciphisa inani lokugqashuka.

I-Herpes Vaccine Research

Kube nokuhlolwa okuthembisayo kwemigomo ye-herpes. Kodwa-ke, kuze kube yimanje, akukho uvivinyo lomuntu oluye lwabonisa ukuphumelela okwanele ukuletha umuthi wokugoma we-herpes ukuthengisa. Lokho kusho ukuthi kukhona ithemba lokuthuthukiswa kokugoma. Ososayensi baye bakwazi ukuvikela amanye amaqembu angaphansi kwabantu ngokumelene nokutheleleka kwe-herpes. Ngaphezu kwalokho, ekuqaleni kuka-2018, kwakukhona okungenani ama-vaccine amane e-HSV ayathuthukiswa.

Ngeshwa, kunezithiyo eziningana ososayensi okufanele babhekane nazo lapho besungula umgomo wokugoma i-herpes. Isimo esikhulu kunazo zonke ukuthi ayikho imfuyo enhle yezilwane okufanele ihlolwe ngayo imishanguzo.

Nakuba amagundane namagundane e-Guinea angatholakala nge-herpes, ukutheleleka kwabo kuhluke kakhulu kubantu besifo sofuba. Lokhu kusho ukuthi imishanguzo eye yabonisa isithembiso ezilwaneni ayiphumelelanga ngokukhethekile kubantu.

Imishanguzo ye-Herpes nayo kunzima ukutadisha ezinye izizathu eziningana ezingokoqobo. Udinga ukuhlola abantu abaningi ukubona ukuthi basebenza yini. Labo bantu kungaba nzima ukuthola. Ngaphezu kwalokho, njengoba abantu abaningi bengenayo izimpawu ze-herpes, awukwazi ukulinda nje ukubona ukuthi abantu banezifo. Kufanele uhlolwe ukuze ubone ukuthi ngabe banegciwane yini. Noma, ukuze uthole imithi yokwelapha, kufanele uhlole ukuthi umuthi wokugoma usithinte kanjani inani legciwane abalichitha . Ukukhuluma nganoma iyiphi yalezi zici kungenza ukuhlolwa kokugoma kuphuze futhi kubize.

Ikusasa le-Herpes Vaccine Research

Emhlabeni jikelele, odokotela kanye nososayensi bayazi ukuthi ukuyeka i-herpes kuyinto ebaluleke kakhulu. Nakuba abantu abaningi abanegciwane lesandulela ngculaza bengenayo izimpawu, i-herpes ingaba nemthelela ebalulekile empilweni yabantu. Lokhu kuyiqiniso ikakhulu kubantu abathintekayo ngesikhathi sokukhulelwa noma abahlala ezindaweni ezine -HIV eziningi.

Yingakho ucwaningo lwe-herpes lokugoma lubaluleke kakhulu. Abantu baqhubeka befuna izindlela ezintsha zokuvimbela izifo ze-herpes nokunciphisa ukuqhuma. Omunye iqembu lokucwaninga, isibonelo, usebenzisa ama-lasers njengengxenye yenqubo yokugoma. Umgomo wabo ukugqugquzela ukuthuthukiswa kwamaseli omzimba emaceleni esikhumba. Kodwa, azikho izimpendulo ezisheshayo. Ngenhlanhla, kunezinye izinketho zokunciphisa ingozi yokudluliselwa kwe-herpes. Kokubili ukwelashwa okucindezelayo nokusebenzisa ubulili obuvikelekile ngokuthembekile kungasiza ekuvikeleni abantu uma abalingani babo bocansi bethelelekile nge-HSV.

> Imithombo:

> Awasthi S, uFriedman HM. Isimo semithi yokuvimbela i-herpes yomzimba ye-prophylactic kanye nokwelapha. I-Curr Opin Virol. 2014 Jun; 6: 6-12.

> I-Ghiasi H. I-Vaccine Evelicous Novel, i-Immunity Immunity, ne-Ocular Herpes Simplex Virus 1: Ingokoqobo noma Inganekwane? J Ukuphuza. 2017 Nov 14; 91 (23). i-pii: e01421-17.

> Gottlieb SL, Giersing BK, uHickling J, Jones R, Deal C, Kaslow DC; I-HSV Vaccine Expert Consultation Group. Umbiko womhlangano: Ukuqala kokubambisana kwe-herpes simplex virus (HSV) okukhethwa yizici zomkhiqizo, ngoMashi 2017. Umuthi wokugoma. 2017 Dec 7. pii: S0264-410X (17) 31492-5.

> I-Lopes PP, Todorov G, i-Pham TT, i-Nesburn AB, i-Bahraoui E, i-Peptide ye-BenMohamed L. Laser Adjuvant-Esizayo Ikhuthaza I-Skin Ukugqugquzela Amaseli E-Dendritic Nokuthuthukiswa I-CD8 (+) T (EM) ne-T (RM) Izimpendulo Zamaselula I-Herpes Infection and Disease (‡). J Ukuphuza. 2018 Feb 7. pii: JVI.02156-17.

> Rajčáni J, Bánáti F, Szenthe K, Szathmary S. Okusemandleni okwamanje okungekho emitholampilo ye-herpes virus. I-Expert Vac Vaccin. 2018 Mar; 17 (3): 239-248. i-doi: 10.1080 / 14760584.2018.1425620.